Products

JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all 1 product →

About JLK-NCCT

JLK-NCCT is an AI-powered healthcare company specializing in medical AI solutions, particularly in the neurological and cancer fields. The company focuses on developing and supplying AI solutions across the entire stroke treatment cycle, from emergency care to chronic-phase prognosis prediction, by analyzing various medical images such as CT, CTP, MRI, and MRA.

Their flagship platform, MEDIHUB STROKE, offers a comprehensive end-to-end solution for brain disorders, including hemorrhage, infarction, aneurysm, and dementia. JLK-NCCT’s AI tools, such as JLK-NCCT, are designed to assist physicians in making faster and more accurate treatment decisions by analyzing non-contrast CT scans—often the first imaging step in stroke emergencies—to detect brain hemorrhages and infarctions. The company also has solutions for prostate cancer detection, lung disease diagnosis, and cerebral aneurysm detection. They have obtained numerous global medical AI product licenses, including from the MFDS (Korea), FDA (U.S.), PMDA (Japan), and CE (Europe).

Focus Areas

AI-based medical platform AI-based medical data management platform stroke diagnosis and treatment cerebral hemorrhage cerebral infarction large vessel occlusion (LVO) dementia analysis cancer analysis medical imaging analysis (CT CTP MRI MRA X-Ray Mammography Pathology)

Business Intelligence

TechnologyAI-based medical platform, cloud-based medical diagnosis tool, integrated mobile medical app (FASTRO, formerly Snappy), AI Telemedicine Platform (MEDIHUB TELE)

What Physicians Need to Know

AI-based Medical Platform
JLK-NCCT specializes in AI-based medical platforms, offering solutions like JLK-AILink, an integrated AI medical imaging platform that manages, views, and shares medical images from various devices (CT, MRI, X-ray) and supports remote access via mobile devices. They also have 'MEDIHUB', an AI medical platform for dementia and cancer solutions.
Stroke Diagnosis & Treatment
JLK-NCCT provides a comprehensive AI-based stroke total solution, 'MEDIHUB STROKE', covering the entire treatment cycle from acute emergency care to chronic-phase prognosis prediction. Their solutions analyze multi-modality medical imaging (CT, CTA, CTP, MRI, MRA) for both hemorrhagic and ischemic strokes. Key products include JLK-NCCT for detecting brain hemorrhages and infarctions on non-contrast CT scans, JLK-ICH for intracranial hemorrhage detection, and JLK-LVO for large vessel occlusion (LVO) detection, even at the non-contrast CT stage.
Cerebral Hemorrhage & Infarction
JLK-NCCT's AI tools are specifically designed for the rapid and accurate detection of cerebral hemorrhage and infarction. Their JLK-NCCT solution analyzes non-contrast CT scans to identify high- and low-density regions, calculate their volume, and improve diagnostic precision for brain hemorrhages and infarctions. JLK-ICH focuses on detecting suspected intracranial hemorrhage and providing automated notifications to clinicians.
Large Vessel Occlusion (LVO)
JLK-NCCT offers AI solutions for the early identification of LVO, which is crucial for timely intervention in ischemic stroke. Their JLK-NCCT solution can screen for patients with suspected LVO even at the non-contrast CT stage, which is typically assessed via CT angiography (CTA). This allows for rapid patient triage and response in the emergency room, playing a pivotal role in the 'golden hour' of stroke treatment.
Dementia Analysis
JLK-NCCT provides precision dementia analysis solutions as part of their 'MEDIHUB Dementia & Cancer Solutions' package. Their JBS-04K system uses 3D convolution neural network technology to classify gray matter regions, calculate cortical thickness from 3D MRI data, and estimate brain aging status.
Cancer Analysis
JLK-NCCT offers precision cancer analysis solutions within their 'MEDIHUB Dementia & Cancer Solutions' package. Their JPC-01K system uses artificial neural networks to detect prostate cancer areas using multiparametric MR images (T2, DWI, DCE), visualizing the location and probability of cancer. They also have JLD-02K for diagnosing lung diseases using chest X-ray images and clinical information.
Medical Imaging Analysis
JLK-NCCT specializes in AI-based medical imaging analysis across a wide range of modalities, including CT, CTP, MRI, MRA, X-Ray, Mammography, and Pathology. Their AI solutions are designed to analyze these images for various conditions, including stroke, dementia, and cancer.
Physician Tip

JLK-NCCT's AI solutions are designed to significantly enhance diagnostic accuracy and speed, particularly in time-critical situations like stroke. Physicians can leverage their tools for early identification of conditions like cerebral hemorrhage and large vessel occlusion from initial non-contrast CT scans, enabling faster triage and treatment decisions. The mobile app integration (FASTRO, formerly Snappy) allows for rapid notifications, improving communication and workflow efficiency in emergency settings. The comprehensive stroke solution covers the entire patient journey, from emergency to rehabilitation, providing support across various imaging modalities. For dementia and cancer, their precision analysis tools offer detailed insights from MRI and other imaging, aiding in diagnosis and treatment planning. The high sensitivity and specificity demonstrated by their AI tools in real-world studies can provide valuable diagnostic support, especially when immediate expert review is unavailable.

JLK-NCCT's JLK-AILink platform is designed for bidirectional communication with hospital PACS systems and imaging equipment (MR, CT, X-ray) via DICOM standards. It integrates a DICOM viewer with image manipulation and annotation tools and supports a modular architecture for integrating optional analysis solutions. The system also supports mobile access and compatibility with containerized environments for data security and management. Their AI solutions are built to create a seamless pathway from initial diagnostic tests to subsequent imaging and treatment.

Products by JLK-NCCT

1 product in the directory

JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

Reviews & Opinions

No web reviews on file yet for JLK-NCCT. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about JLK-NCCT.

Loading videos...

Videos load interactively. If none appear, search YouTube for JLK-NCCT →

View all on YouTube

Press & Coverage

Korea Biomedical Review
JLK gains FDA 510(k) clearance for NCCT-based AI stroke detection tool
JLK announced that its non-contrast CT (NCCT)-based stroke analysis solution, JLK-NCCT, received FDA 510(k) clearance from the U.S. Food and Drug Administration, recognizing its clinical value in rapid identification and prioritization of suspected stroke patients.
2026-03
Korea Biomedical Review
JLK wins Japan's approval for AI stroke diagnosis tool
JLK received regulatory approval in Japan from the Pharmaceuticals and Medical Devices Agency (PMDA) for its AI-powered stroke diagnosis tool, NCCT, for detecting brain hemorrhages and infarctions.
2025-02
Korea Biomedical Review
JLK to showcase AI stroke solutions at ISC 2026 in New Orleans
JLK will participate in the International Stroke Conference (ISC) 2026 to showcase its AI-based stroke diagnosis and treatment decision-support solutions, aiming to expand its presence in the U.S. market.
2026-01
Korea Biomedical Review
JLK snags 4th Japan nod for stroke AI, targets underserved hospitals
JLK received its fourth regulatory approval in Japan from the PMDA for its MRI-based stroke diagnosis solution, JLK-FLAIR, expanding its AI suite for stroke to address specialist shortages.
2025-03
Korea Biomedical Review
JLK notches 7th FDA nod for AI stroke detection as 8 more line up in US push
JLK obtained FDA 510(k) clearance for JLK-SDH, its AI-powered subdural hemorrhage (SDH) detection tool, bringing its FDA-cleared portfolio to seven and signaling a strong focus on the U.S. market.
2025-03
MK
JLK, a medical artificial intelligence (AI) company, announced on the 28th that it has obtained a Ja.. - MK
JLK announced it has obtained a Japanese license for its brain MRI imaging AI solution 'JLK-GRE', increasing its medical imaging AI solution licenses in Japan to six and aiming to expand MRI-based solutions.
2025-04
AuntMinnie
JLK expands access to AI-based TB screening tool
JLK Inspection signed an agreement with the Clinton Health Initiative and the National Tuberculosis Center to expand access to tuberculosis (TB) screenings in Laos using its AI-based lung disease analysis algorithm JLD-02K.
2020-02

Frequently Asked Questions

JLK-NCCT provides AI-powered platforms designed to assist in the diagnosis and treatment of stroke, including solutions for cerebral hemorrhage, cerebral infarction, and large vessel occlusion (LVO). These platforms leverage AI to analyze medical images and provide insights to physicians.
JLK-NCCT's AI platform is designed for seamless integration with various medical imaging modalities such as CT, CTP, MRI, MRA, X-Ray, Mammography, and Pathology. It performs advanced analysis on these images to aid in the detection and characterization of conditions like stroke, dementia, and various cancers.
JLK-NCCT adheres to relevant compliance standards and has obtained necessary regulatory approvals for its AI-based medical devices and data management platforms. This ensures the safety, efficacy, and data privacy of their solutions in clinical settings.
JLK-NCCT offers various pricing structures and support models for its AI solutions, which may include subscription-based services or per-use options tailored to the needs of different healthcare institutions. Detailed information on pricing and support can be obtained through direct consultation.
JLK-NCCT actively pursues partnerships with leading healthcare organizations and technology providers to enhance its AI offerings and expand its reach. These collaborations often focus on research, development, and the integration of their AI solutions into broader healthcare ecosystems.
JLK-NCCT is committed to long-term stability and continuous innovation in the field of AI-based medical platforms. The company has a clear vision for ongoing research, development, and robust support to ensure the sustained value and effectiveness of its solutions for healthcare providers.
JLK-NCCT's AI platform extends beyond stroke to include advanced analysis for dementia and various cancers. By processing medical images, the AI assists in identifying subtle indicators and patterns, thereby supporting earlier diagnosis and more precise treatment planning for these complex conditions.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.